Journal of International Oncology››2015,Vol. 42››Issue (1): 74-76.doi:10.3760/cma.j.issn.1673-422X.2015.01.020

Previous ArticlesNext Articles

Status analysis of gene therapy in osteosarcoma

Zhang Ning, You Jianyu, Guo Weina, Zhao Baolin

  1. Department of Orthopedics,China-Japan Union Hospital,JilinUniversity,Changchun 130021,China
  • Received:2014-06-18Revised:2014-08-05Online:2015-01-08Published:2015-01-07
  • Contact:Zhao Baolin E-mail:zhaobl@163.com

Abstract:At present, the medical profession generally acknowledged the best way to treat osteosarcoma is gene therapy, which includes tumor suppressor gene therapy, antisense gene therapy, suicide gene therapy, immune gene therapy, combined gene therapy, etc. But no matter what kind of gene therapy is that the gene must have a safe carrier. Gene therapy has made a breakthrough in osteosarcoma recently. On the basis of widespread use, we should emphasize the importance of gene vectors.

Key words:Osteosarcoma,Gene therapy,Genetic vectors